Form 4 for VIR Vir Biotechnology, Inc.
Accepted 2022-02-24 00:00:00 ET · period of report 2022-02-22 · accession 0001209191-22-012952 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-24 | 2022-02-22 | VIR | Virgin Herbert | EVP, CSO, Research | M - OptEx | $1.53 | +1,375 | 176.8K | +0.8% | +$2,104 |
| D | 2022-02-24 | 2022-02-22 | VIR | Virgin Herbert | EVP, CSO, Research | S - Sale+OE | $30.00 | -1,375 | 175.4K | -0.8% | -$41.2K |
| D | 2022-02-24 | 2022-02-22 | VIR | Virgin Herbert | EVP, CSO, Research | A - Grant | $0.00 | +70.0K | 175.4K | +66% | $0 |
| D | 2022-02-24 | 2022-02-22 | VIR | Virgin Herbert | EVP, CSO, Research | M - OptEx | $0.00 | -1,375 | 219.5K | -0.6% | $0 |
| D | 2022-02-24 | 2022-02-22 | VIR | Virgin Herbert | EVP, CSO, Research | A - Grant | $0.00 | +70.0K | 70.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-22 | M | A | 1,375 | $1.53 | 176,782 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-22 | S | D | 1,375 | $30.00 | 175,407 | D | — | — | |
| 3 | Common | Common Stock | 2022-02-22 | A | A | 70,000 | $0.00 | 175,407 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2022-02-22 | M | D | 1,375 | $0.00 | 219,505 | D | $1.53 · — to 2028-01-26 | 1,375 Common Stock | (F3) The option is fully vested and exercisable. |
| 5 | Derivative | Stock Option (Right to Buy) | 2022-02-22 | A | A | 70,000 | $0.00 | 70,000 | D | $29.48 · — to 2032-02-21 | 70,000 Common Stock | (F4) 25% of the shares subject to the stock option vest and become exercisable on February 22, 2023, and the remainder vest in 36 equal monthly installments thereafter. |